New Antipsychotic Drugs Criticized: Federal Study Finds No Benefit Over Older, Cheaper Drug
Info Document Actions Print this A front page Washington Post article about a federal study that “challenges widespread assumptions” about one of psychiatry’s most frequently-used drugs quotes David Oaks, MindFreedom International director. A MindFreedom analysis follows. New Antipsychotic Drugs Criticized: Federal Study Finds No Benefit Over Older, Cheaper Drug Date Published: Sep 20, 2005 01:00…